BillionToOne, Inc. (BLLN) vs Erasca, Inc. (ERAS)

A side-by-side comparison of BillionToOne, Inc. and Erasca, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BillionToOne, Inc. logo
BLLN
BillionToOne, Inc.
$4.60B
$99.90HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Erasca, Inc. logo
ERAS
Erasca, Inc.
$4.96B
$14.30HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BLLN vs ERAS

growth of $100 · dividends reinvested · last 1y
BLLN +0.1% (+0.1%/yr)ERAS +569.1% (+569.1%/yr)ERAS compounded faster over this window
Log scale — wide-divergence pair
101001kStart $1002026$100$669
BLLN ERAS

BLLN vs ERAS: by the numbers

  • •ERAS is the larger company ($4.96B vs $4.60B market cap).
  • •BLLN is profitable (8.43% net margin) while ERAS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricBLLNERAS
P/E ratio161.11N/A
Forward P/E125.78N/A
P/S ratio11.56N/A
P/B ratio8.5613.72
EV / EBITDA75.37N/A
FCF yield0.72%N/A

Profitability

MetricBLLNERAS
Gross margin71.27%0.00%
Operating margin10.90%0.00%
Net margin8.43%0.00%
ROE6.24%-79.37%
ROIC6.39%-38.03%

Growth (annualized)

MetricBLLNERAS
Total return CAGR (5Y)N/A-8.34%

Frequently asked

Is BLLN or ERAS more profitable?
BLLN runs the higher net margin — BLLN at 8.43% versus ERAS at 0.00%.

Go deeper

Full BLLN analysisFull ERAS analysisInteractive comparison tool

Dig into the metrics

BillionToOne P/E ratioBillionToOne ROEErasca ROEBillionToOne operating marginErasca operating marginBillionToOne revenue growthErasca revenue growthBillionToOne free cash flowErasca free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.